Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 45

1.

The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer.

Hofmann E, Seeboeck R, Jacobi N, Obrist P, Huter S, Klein C, Oender K, Wiesner C, Hundsberger H, Eger A.

Biomark Res. 2016 Apr 7;4:8. doi: 10.1186/s40364-016-0062-7. eCollection 2016.

2.
3.

Alpha-catulin contributes to drug-resistance of melanoma by activating NF-κB and AP-1.

Kreiseder B, Holper-Schichl YM, Muellauer B, Jacobi N, Pretsch A, Schmid JA, de Martin R, Hundsberger H, Eger A, Wiesner C.

PLoS One. 2015 Mar 20;10(3):e0119402. doi: 10.1371/journal.pone.0119402. eCollection 2015.

4.

Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression.

Bakiri L, Macho-Maschler S, Custic I, Niemiec J, Guío-Carrión A, Hasenfuss SC, Eger A, Müller M, Beug H, Wagner EF.

Cell Death Differ. 2015 Feb;22(2):336-50. doi: 10.1038/cdd.2014.157. Epub 2014 Oct 10.

5.

eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation.

Spilka R, Ernst C, Bergler H, Rainer J, Flechsig S, Vogetseder A, Lederer E, Benesch M, Brunner A, Geley S, Eger A, Bachmann F, Doppler W, Obrist P, Haybaeck J.

Cell Oncol (Dordr). 2014 Aug;37(4):253-67. doi: 10.1007/s13402-014-0181-9. Epub 2014 Jul 29.

PMID:
25070653
6.

Antimicrobial and anti-inflammatory activities of endophytic fungi Talaromyces wortmannii extracts against acne-inducing bacteria.

Pretsch A, Nagl M, Schwendinger K, Kreiseder B, Wiederstein M, Pretsch D, Genov M, Hollaus R, Zinssmeister D, Debbab A, Hundsberger H, Eger A, Proksch P, Wiesner C.

PLoS One. 2014 Jun 2;9(6):e97929. doi: 10.1371/journal.pone.0097929. eCollection 2014.

7.

Rapid soil production and weathering in the Southern Alps, New Zealand.

Larsen IJ, Almond PC, Eger A, Stone JO, Montgomery DR, Malcolm B.

Science. 2014 Feb 7;343(6171):637-40. doi: 10.1126/science.1244908. Epub 2014 Jan 16.

PMID:
24436184
8.

Novel Aeruginosin-865 from Nostoc sp. as a potent anti-inflammatory agent.

Kapuścik A, Hrouzek P, Kuzma M, Bártová S, Novák P, Jokela J, Pflüger M, Eger A, Hundsberger H, Kopecký J.

Chembiochem. 2013 Nov 25;14(17):2329-37. doi: 10.1002/cbic.201300246. Epub 2013 Oct 2.

PMID:
24123716
9.

Real-time monitoring of relative peptide-protein interaction strengths in the yeast two-hybrid system.

Rid R, Herzog J, Maier RH, Hundsberger H, Eger A, Hintner H, Bauer JW, Onder K.

Assay Drug Dev Technol. 2013 May;11(4):269-75. doi: 10.1089/adt.2012.496.

PMID:
23679850
10.

Delayed paraplegia due to "surgiceloma" following thoracotomy for a Pancoast tumor.

Schatlo B, Eger AF, Schaller K, Tessitore E.

Acta Neurochir (Wien). 2013 Jul;155(7):1243-4. doi: 10.1007/s00701-013-1703-3. Epub 2013 Apr 17. No abstract available.

PMID:
23591929
11.

A combined impedance and AlphaLISA-based approach to identify anti-inflammatory and barrier-protective compounds in human endothelium.

Pflüger M, Kapuscik A, Lucas R, Koppensteiner A, Katzlinger M, Jokela J, Eger A, Jacobi N, Wiesner C, Hofmann E, Onder K, Kopecky J, Schütt W, Hundsberger H.

J Biomol Screen. 2013 Jan;18(1):67-74. doi: 10.1177/1087057112458316. Epub 2012 Aug 30.

PMID:
22941294
12.

Interaction of tumor cells with the immune system: implications for dendritic cell therapy and cancer progression.

Imhof M, Karas I, Gomez I, Eger A, Imhof M.

Drug Discov Today. 2013 Jan;18(1-2):35-42. doi: 10.1016/j.drudis.2012.07.010. Epub 2012 Jul 27. Review.

PMID:
22842550
13.

PIM-1 kinase interacts with the DNA binding domain of the vitamin D receptor: a further kinase implicated in 1,25-(OH)2D3 signaling.

Maier CJ, Maier RH, Rid R, Trost A, Hundsberger H, Eger A, Hintner H, Bauer JW, Onder K.

BMC Mol Biol. 2012 Jun 21;13:18. doi: 10.1186/1471-2199-13-18.

14.

NF-κB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells.

Vonach C, Viola K, Giessrigl B, Huttary N, Raab I, Kalt R, Krieger S, Vo TP, Madlener S, Bauer S, Marian B, Hämmerle M, Kretschy N, Teichmann M, Hantusch B, Stary S, Unger C, Seelinger M, Eger A, Mader R, Jäger W, Schmidt W, Grusch M, Dolznig H, Mikulits W, Krupitza G.

Br J Cancer. 2011 Jul 12;105(2):263-71. doi: 10.1038/bjc.2011.194. Epub 2011 May 31.

15.

CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells.

Amatschek S, Lucas R, Eger A, Pflueger M, Hundsberger H, Knoll C, Grosse-Kracht S, Schuett W, Koszik F, Maurer D, Wiesner C.

Br J Cancer. 2011 Feb 1;104(3):469-79. doi: 10.1038/sj.bjc.6606056. Epub 2010 Dec 21.

16.

The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer.

Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A, Bauer K, Sultan A, Hlubek F, Jung A, Strand D, Eger A, Kirchner T, Behrens J, Brabletz T.

Cancer Res. 2008 Jan 15;68(2):537-44. doi: 10.1158/0008-5472.CAN-07-5682.

17.

The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.

Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M, Mikulits W, Brabletz T, Strand D, Obrist P, Sommergruber W, Schweifer N, Wernitznig A, Beug H, Foisner R, Eger A.

Oncogene. 2007 Oct 25;26(49):6979-88. Epub 2007 May 7.

18.

The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression.

Aigner K, Descovich L, Mikula M, Sultan A, Dampier B, Bonné S, van Roy F, Mikulits W, Schreiber M, Brabletz T, Sommergruber W, Schweifer N, Wernitznig A, Beug H, Foisner R, Eger A.

FEBS Lett. 2007 Apr 17;581(8):1617-24. Epub 2007 Mar 21.

19.

A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer.

Spaderna S, Schmalhofer O, Hlubek F, Berx G, Eger A, Merkel S, Jung A, Kirchner T, Brabletz T.

Gastroenterology. 2006 Sep;131(3):830-40.

PMID:
16952552
20.

Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells.

Pacher M, Seewald MJ, Mikula M, Oehler S, Mogg M, Vinatzer U, Eger A, Schweifer N, Varecka R, Sommergruber W, Mikulits W, Schreiber M.

Carcinogenesis. 2007 Jan;28(1):49-59. Epub 2006 Jun 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk